INTEGRATIVE APPROACH TO KASHTARTAVA (PRIMARY DYSMENORRHEA): A CLINICAL CASE STUDY ON AYURVEDIC INTERVENTION AND PAIN MANAGEMENT
DOI:
https://doi.org/10.22159/prl.ijayush.v14i02.1251Keywords:
Primary Dysmenorrhea, Kashtartava, Vata Dosha, Panchakarma, Ayurvedic Treatment, Yonishoola PrashamanaAbstract
Background: Primary Dysmenorrhea (Kashtartava) is a common gynecological disorder caused by Vata Dosha vitiation, leading to uterine spasms and pain. Conventional treatments, including NSAIDs and hormonal therapy, may have side effects. Ayurveda offers a holistic approach through Panchakarma, herbal formulations, and lifestyle modifications. Case Presentation: A 20-year-old female with severe lower abdominal pain during menstruation (past four years) experienced fatigue, nausea, and mood swings. Her regular menstrual cycle (28-30 days) showed no structural abnormalities on USG. Previous analgesic use provided only temporary relief. Intervention: Panchakarma Therapy: Abhyanga with Dhanvantaram Taila – 15 min daily Swedana with Dashamoola Kwatha – 10 min daily. Basti Karma (Dashamoola Niruha Basti, Anuvasana Basti on alternate days) Oral Medications: Ashwagandha Churna, Shatavari Kalpa, Hingwashtaka Churna, Triphala Guggulu Diet & Lifestyle: Pathya Ahara (Vata-Pitta pacifying diet). Yoga & Pranayama (Baddha Konasana, Supta Baddha Konasana, Anulom-Vilom) Outcome: Pain intensity reduced from VAS 8/10 to 2/10 by the third cycle, with improved digestion, energy levels, and emotional well-being, eliminating the need for analgesics. Conclusion: This case highlights the efficacy of Ayurvedic management in treating Kashtartava by addressing the root cause rather than symptomatic relief. A combination of Panchakarma, herbal therapy, diet, and lifestyle modifications provides a safe, holistic, and effective approach to Primary Dysmenorrhea. Further clinical trials are needed to validate these findings.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dr. Priyanka Singh, Dr. Jasmine

This work is licensed under a Creative Commons Attribution 4.0 International License.
